Researchers Develop New Cells Meant to Form Blood Vessels, Treat Peripheral Artery Disease
Researchers have developed a technique to jump-start the body’s systems for creating blood vessels, opening the door for potential new treatments for diseases whose impacts include amputation and blindness. They developed a novel methodology to mature the induced pluripotent stem cells into cells with the characteristics of the endothelial colony-forming cells that are found in umbilical cord blood. [Press release from the Indiana University School of Medicine discussing publication in Nature Biotechnology] Press Release|Abstract|Video
6-O-Sulfated Chitosan Promoting the Neural Differentiation of Mouse Embryonic Stem Cells
As a type of sulfated glycosaminoglycan analog, sulfated chitosan with well-defined sulfation sites and a controlled degree of sulfation were prepared through simple procedures and the influence of sulfated glycosaminoglycan on neural differentiation of embryonic stem cells was investigated. [ACS Appl Mater Interfaces] Abstract
Human Induced Pluripotent Stem Cell and Nanotechnology-Based Therapeutics
The authors review recent advances in cellular reprogramming and human induced pluripotent stem cells-related research, such as cell source, delivery system and direct reprogramming, as well as some of its potential clinical applications, including mitochondrial and retinal disease. [Cell Transplant] Full Article
Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field.
INDUSTRY NEWS
Four UCLA Scientists Receive NIH Innovator Award for Stem Cell, Neuroscience Research
Four scientists from the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at University of Calfornia, Los Angeles (UCLA) have received a National Institutes of Health (NIH) Director’s New Innovator Award for advancing revolutionary stem cell and neuroscience in medicine. The four UCLA researchers were among only 50 recipients nationwide and the most from a single institution represented. [University of Calfornia, Los Angeles] Press Release
Marius Wernig Receives New York Stem Cell Foundation’s Robertson Stem Cell Prize
The New York Stem Cell Foundation (NYSCF) announced that Marius Wernig, PhD, Associate Professor in the Institute for Stem Cell Biology and Regenerative Medicine and the Department of Pathology at Stanford University School
of Medicine, is the 2014 recipient of the NYSCF – Robertson Stem Cell Prize, which has been awarded since 2011 for extraordinary achievements in translational stem cell research by a young scientist. [New York Stem Cell Foundation] Press Release
NIH Makes $32 Million in Awards to Mine Big Data
Hoping to tame the torrent of data churning out of biology labs, the National Institutes of Health (NIH) today announced $32 million in awards in 2014 to help researchers develop ways to analyze and use large biological data sets. [ScienceInsider] Editorial
Stem Cells for Diabetes: The Danger of the Word ‘Cure’
There has been considerable discussion about the whether the media hyped the recent Harvard Diabetes stem cell paper. This Harvard publication reported production of insulin-secreting cells from human embryonic stem cells. Newspapers around the world widely exaggerated the potential impact of this paper. They often used the word “cure”. [Knoepfler Lab Blog] Editorial
Stem-Cell Fraud Makes for Box Office Success
A movie based on the Woo Suk Hwang cloning scandal drew more than 100,000 viewers on its opening day (2 October) and has been topping box office sales in South Korea since then. With some of the country’s biggest stars, it has made a blockbuster out of a dismal episode in South Korean stem-cell research – and revealed the enduring tension surrounding it. [Nature] Editorial
Recruit Top Talent: Reach more than 50,000 potential candidates by posting
your organization’s career opportunities on the Connexon Creative Job Board at no cost.
Have we missed an important article or publication in ESC & iPSC News? Click here to submit!
